Sensei Biotherapeutics
Sensei Biotherapeutics is a clinical-stage immunotherapy company that engages in the discovery and development of next generation therapies with a primary focus on the treatments for cancer.
2
Funding Rounds
$128.5m
Money raised
| Name | Phone | Social networks | |
|---|---|---|---|
| Sa**** Br**** | - | - | - |
| Ja*** Pe*** | - | - | linkedin twitter |
| Bo* Ho**** | - | - | |
| To* Ri*** | - | - | - |
| Jo** K. Ce**** | - | - | - |
| Wi***** Ri*** | - | - | - |
| Je**** En***** | - | - | - |
| Kr****** Hu*** | - | - | - |
| De**** Vo*** | - | - | - |
Funding series
Funding Series Analysis
The company Sensei Biotherapeutics has raised a total of $28.5m in funding over 2 rounds.
Key Insights:
- Sensei Biotherapeutics , October 2020: $28.5m
- Sensei Biotherapeutics Series E round January 2021: $100m
Sensei Biotherapeutics , October 2020
$28.5m
Sensei Biotherapeutics Series E round January 2021
$100m
Industries
Sensei Biotherapeutics is active in the following industries:
- Life science
- Therapeutics
- Medical diagnostics
- Biomedical engineering
- Biopharmaceutical
- Proteomics
- Cancer
- Oncology
- Engineering
- Technology
- Biology
- Biotechnology
- Internal medicine
- Healthcare
- Medicine